Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
hot flashes
Glycididazole
chemoradiotherapy
,
esophageal neoplasms
,
carcinoma
,
squamous cell carcinoma
Taxane
inflammatory breast neoplasms
,
paraneoplastic syndromes
,
ovarian neoplasms
,
esophageal neoplasms
,
recurrence
,
adenocarcinoma
,
pancreatic neoplasms
,
ovarian epithelial carcinoma
,
nasopharyngeal neoplasms
,
endometrial neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
germ cell and embryonal neoplasms
,
nasopharyngeal carcinoma
,
urinary bladder neoplasms
,
ductal carcinoma
,
male breast neoplasms
,
carcinosarcoma
,
triple negative breast neoplasms
,
peritoneal neoplasms
,
diarrhea
,
hepatocellular carcinoma
,
liver neoplasms
,
residual neoplasm
,
mouth neoplasms
,
gastrointestinal diseases
,
testicular neoplasms
,
uterine neoplasms
,
endometrioid carcinoma
,
breast neoplasms
,
neoplasms
,
stomach neoplasms
,
neoplasm metastasis
,
squamous cell neoplasms
,
squamous cell carcinoma
,
carcinoma
,
laryngeal neoplasms
,
local neoplasm recurrence
,
hypopharyngeal neoplasms
,
lobular carcinoma
,
ductal carcinoma breast
,
brain stem neoplasms
,
castration-resistant prostatic neoplasms
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
head and neck neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use